Cleared Special

K994219 - AT HOME DRUG TEST, MODEL 9073
(FDA 510(k) Clearance)

Dec 1999
Decision
15d
Days
Class 2
Risk

K994219 is an FDA 510(k) clearance for the AT HOME DRUG TEST, MODEL 9073. This device is classified as a Enzyme Immunoassay, Cocaine And Cocaine Metabolites (Class II - Special Controls, product code DIO).

Submitted by Phamatech (San Diego, US). The FDA issued a Cleared decision on December 30, 1999, 15 days after receiving the submission on December 15, 1999.

This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3250.

Submission Details

510(k) Number K994219 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 15, 1999
Decision Date December 30, 1999
Days to Decision 15 days
Submission Type Special
Review Panel Toxicology (TX)
Summary Summary PDF

Device Classification

Product Code DIO — Enzyme Immunoassay, Cocaine And Cocaine Metabolites
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3250

Similar Devices — DIO Enzyme Immunoassay, Cocaine And Cocaine Metabolites

All 144
Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Enzyme Immunoassay (COCM) Test System
K213211 · Carolina Liquid Chemistries Corp. · Jan 2022
DRI Cocaine Metabolite Assay
K211973 · Microgenics Corporation · Sep 2021
Pointe Scientific Cocaine Metabolite Enzyme Immunoassay
K191638 · Medtest DX · Mar 2020
DRI Cocaine Metabolite Assay
K181499 · Microgenics Corporation · Jul 2018
Emit II Plus Cocaine Metabolite Assay
K170293 · Siemens Healthcare Diagnostics, Inc. · Oct 2017
Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Test System (COCM)
K163570 · Carolina Liquid Chemistries Corporation · Aug 2017